Mettler-Toledo International Inc. (NYSE:MTD) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Mettler-Toledo International Inc. (NYSE:MTDGet Rating) have been given an average rating of “Moderate Buy” by the eight ratings firms that are currently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $1,396.00.

Several brokerages recently weighed in on MTD. JPMorgan Chase & Co. raised shares of Mettler-Toledo International from an “underweight” rating to a “neutral” rating and raised their target price for the company from $1,100.00 to $1,350.00 in a report on Monday, December 19th. StockNews.com raised shares of Mettler-Toledo International from a “buy” rating to a “strong-buy” rating in a report on Wednesday. Wells Fargo & Company raised their target price on shares of Mettler-Toledo International from $1,410.00 to $1,650.00 and gave the company an “overweight” rating in a report on Tuesday, January 10th. The Goldman Sachs Group upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price target for the company from $1,120.00 to $1,355.00 in a research note on Tuesday, November 8th. Finally, Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,406.00 to $1,284.00 in a research note on Friday, November 4th.

Mettler-Toledo International Stock Up 2.8 %

Shares of MTD opened at $1,561.53 on Friday. The stock has a market capitalization of $34.81 billion, a PE ratio of 42.73, a P/E/G ratio of 2.98 and a beta of 1.19. Mettler-Toledo International has a 1 year low of $1,065.55 and a 1 year high of $1,571.96. The company has a debt-to-equity ratio of 250.82, a quick ratio of 0.74 and a current ratio of 1.13. The company’s 50-day simple moving average is $1,463.02 and its 200-day simple moving average is $1,315.60.

Mettler-Toledo International (NYSE:MTDGet Rating) last issued its earnings results on Thursday, November 3rd. The medical instruments supplier reported $10.18 earnings per share for the quarter, beating the consensus estimate of $9.83 by $0.35. The firm had revenue of $985.80 million for the quarter, compared to analysts’ expectations of $973.68 million. Mettler-Toledo International had a net margin of 21.48% and a return on equity of 1,929.28%. The firm’s revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the company earned $8.72 earnings per share. Analysts forecast that Mettler-Toledo International will post 39.02 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other news, Director Robert F. Spoerry sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, November 7th. The shares were sold at an average price of $1,300.00, for a total transaction of $2,600,000.00. Following the transaction, the director now directly owns 6,548 shares in the company, valued at $8,512,400. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, Director Robert F. Spoerry sold 2,000 shares of the stock in a transaction on Monday, November 7th. The stock was sold at an average price of $1,300.00, for a total transaction of $2,600,000.00. Following the completion of the sale, the director now directly owns 6,548 shares of the company’s stock, valued at $8,512,400. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Shawn Vadala sold 880 shares of the stock in a transaction on Monday, November 7th. The stock was sold at an average price of $1,299.43, for a total value of $1,143,498.40. Following the sale, the chief financial officer now directly owns 4,900 shares of the company’s stock, valued at $6,367,207. The disclosure for this sale can be found here. Insiders have sold 37,073 shares of company stock worth $52,372,537 over the last three months. Insiders own 2.80% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MTD. Greenleaf Trust grew its holdings in shares of Mettler-Toledo International by 1.0% during the 3rd quarter. Greenleaf Trust now owns 717 shares of the medical instruments supplier’s stock worth $777,000 after purchasing an additional 7 shares during the period. Albert D Mason Inc. raised its position in shares of Mettler-Toledo International by 0.5% in the 4th quarter. Albert D Mason Inc. now owns 1,517 shares of the medical instruments supplier’s stock valued at $2,193,000 after purchasing an additional 7 shares in the last quarter. Allworth Financial LP increased its holdings in shares of Mettler-Toledo International by 43.8% in the 4th quarter. Allworth Financial LP now owns 23 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 7 shares during the last quarter. Stock Yards Bank & Trust Co. increased its holdings in shares of Mettler-Toledo International by 1.5% in the 2nd quarter. Stock Yards Bank & Trust Co. now owns 533 shares of the medical instruments supplier’s stock valued at $612,000 after acquiring an additional 8 shares during the last quarter. Finally, Fulton Bank N.A. grew its stake in Mettler-Toledo International by 0.7% during the 4th quarter. Fulton Bank N.A. now owns 1,227 shares of the medical instruments supplier’s stock worth $1,773,000 after buying an additional 8 shares during the last quarter. Hedge funds and other institutional investors own 91.94% of the company’s stock.

About Mettler-Toledo International

(Get Rating)

Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

See Also

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.